KR20220150919A - 중간엽 계통 전구체 또는 줄기 세포를 사용한 염증성 폐 질환의 치료 방법 - Google Patents

중간엽 계통 전구체 또는 줄기 세포를 사용한 염증성 폐 질환의 치료 방법 Download PDF

Info

Publication number
KR20220150919A
KR20220150919A KR1020227033563A KR20227033563A KR20220150919A KR 20220150919 A KR20220150919 A KR 20220150919A KR 1020227033563 A KR1020227033563 A KR 1020227033563A KR 20227033563 A KR20227033563 A KR 20227033563A KR 20220150919 A KR20220150919 A KR 20220150919A
Authority
KR
South Korea
Prior art keywords
cells
subject
stem cells
mesenchymal lineage
mlpscs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227033563A
Other languages
English (en)
Korean (ko)
Inventor
실비우 이떼스쿠
Original Assignee
메조블라스트 인터내셔널 에스에이알엘
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2020900685A external-priority patent/AU2020900685A0/en
Application filed by 메조블라스트 인터내셔널 에스에이알엘 filed Critical 메조블라스트 인터내셔널 에스에이알엘
Publication of KR20220150919A publication Critical patent/KR20220150919A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
KR1020227033563A 2020-03-05 2021-03-04 중간엽 계통 전구체 또는 줄기 세포를 사용한 염증성 폐 질환의 치료 방법 Pending KR20220150919A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020900685A AU2020900685A0 (en) 2020-03-05 Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
AU2020900685 2020-03-05
PCT/EP2021/055483 WO2021176001A1 (en) 2020-03-05 2021-03-04 Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells

Publications (1)

Publication Number Publication Date
KR20220150919A true KR20220150919A (ko) 2022-11-11

Family

ID=74867509

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227033563A Pending KR20220150919A (ko) 2020-03-05 2021-03-04 중간엽 계통 전구체 또는 줄기 세포를 사용한 염증성 폐 질환의 치료 방법

Country Status (9)

Country Link
US (1) US20230293589A1 (enExample)
EP (1) EP4114418B1 (enExample)
JP (1) JP2023517035A (enExample)
KR (1) KR20220150919A (enExample)
CN (1) CN115361958A (enExample)
AU (1) AU2021232614A1 (enExample)
BR (1) BR112022017557A2 (enExample)
CA (1) CA3170255A1 (enExample)
WO (1) WO2021176001A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4663241A3 (en) 2010-10-08 2026-03-25 Mesoblast International Sàrl Enhanced msc preparations
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
IL299997A (en) * 2020-07-20 2023-03-01 Brainstorm Cell Therapeutics Ltd Methods and preparations for the treatment of lung conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
EP2298863B1 (en) * 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
EP4663241A3 (en) * 2010-10-08 2026-03-25 Mesoblast International Sàrl Enhanced msc preparations
WO2015016761A2 (en) * 2013-08-01 2015-02-05 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
CN105796598A (zh) * 2014-12-29 2016-07-27 西比曼生物科技（上海）有限公司 一种用于治疗慢性阻塞性肺疾病的脂肪间充质祖细胞复合物
CN110139657A (zh) * 2017-02-15 2019-08-16 日本乐敦制药株式会社 肺纤维化治疗剂、ptprr表达促进剂及肺纤维化治疗用试剂盒
CL2017002357A1 (es) * 2017-09-16 2018-04-20 Cells For Cells S A Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos
CN111297899A (zh) * 2020-02-21 2020-06-19 云南雅盛医疗科技有限公司 一种脐带间充质干细胞在制备治疗新型冠状肺炎药物中的应用

Also Published As

Publication number Publication date
WO2021176001A1 (en) 2021-09-10
AU2021232614A1 (en) 2022-09-29
BR112022017557A2 (pt) 2022-12-27
EP4114418A1 (en) 2023-01-11
CA3170255A1 (en) 2021-09-10
JP2023517035A (ja) 2023-04-21
EP4114418B1 (en) 2026-05-20
US20230293589A1 (en) 2023-09-21
CN115361958A (zh) 2022-11-18

Similar Documents

Publication Publication Date Title
US20230165904A1 (en) Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells
KR20220143092A (ko) 만성 이식편 대 숙주 질환의 치료 방법
KR20220152240A (ko) 염증성 장 질환 ii의 치료 방법
US20230293589A1 (en) Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
AU2021323475A1 (en) A composition comprising mesenchymal precursor or stem cells and their use
US20230172991A1 (en) Method for treating inflammatory bowel disease i
US20240207323A1 (en) Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precursor or stem cells
KR20230119676A (ko) 클래스 ii 심부전 환자의 진행성 심부전 치료 방법
WO2023119239A1 (en) Method of treating severe graft versus host disease
CN117337184A (zh) 使用间充质谱系前体细胞或干细胞治疗急性呼吸窘迫综合征(ards)的方法
WO2025046491A1 (en) Third line treatment for gvhd
EP4264275A2 (en) Method of treating progressive heart failure in subjects with class ii heart failure

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20220927

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240304

Comment text: Request for Examination of Application